SHTDY:OTCMKTS
Sinopharm Group ADR
$9.40
arrow_upward
+0.40%(+0.038) 1D
Okt 5, 12:54:29 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa SHTDY...
Buksan
$9.21
Mataas
$9.63
Mababa
$9.21
Mkt. cap
45.90B
Avg. na dami
194.14K
Dami
17.39K
Mataas nang 52-wk
$14.87
Mababa nang 52-wk
$9.05
Beta
0.10
Mga natitirang share
268.36M
Bilang ng mga empleyado
90K
Buksan
$9.21
Mataas
$9.63
Mababa
$9.21
Mkt. cap
45.90B
Avg. na dami
194.14K
Dami
17.39K
Mataas nang 52-wk
$14.87
Mababa nang 52-wk
$9.05
Beta
0.10
Mga natitirang share
268.36M
Bilang ng mga empleyado
90K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Reuters
·
1 oras ang nakalipas
S&P 500 up, Nasdaq at record high as megacap tech stocks rise
Goldman Sachs
·
1 linggo ang nakalipas
Can AI Investment Drive S&P 500 Earnings Even Higher?
MarketWatch
·
3 araw ang nakalipas
The stock market is anything but normal right now — and these charts show it
Bloomberg.com
·
5 araw ang nakalipas
Stocks and Bonds Pause Ahead of US Data, Micron: Markets Wrap
Profile
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Tungkol sa Sinopharm Group ADR